Spots Global Cancer Trial Database for gastrointestinal cancers
Every month we try and update this database with for gastrointestinal cancers cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R | NCT02045368 | Breast Cancer Brain Cancer Gastrointestina... Genitourinary C... Gynecologic Can... Head and Neck C... Melanoma Thoracic Cancer... | IGF-Methotrexat... | 18 Years - | IGF Oncology, LLC | |
| Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors | NCT04336241 | Cancer | RP2 nivolumab | 18 Years - | Replimune Inc. | |
| Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy | NCT00849979 | Gastrointestina... | Questionnaire Interview | 18 Years - | M.D. Anderson Cancer Center | |
| A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer | NCT03929666 | HER2-expressing... | ZW25 (Zanidatam... Capecitabine Cisplatin Fluorouracil Leucovorin Oxaliplatin Bevacizumab Gemcitabine | 18 Years - | Jazz Pharmaceuticals | |
| Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers | NCT01200121 | Malignant Ascit... Gastrointestina... | Bevacizumab Placebo | 18 Years - | AIO-Studien-gGmbH | |
| Transitoriness in Cancer Patients, Psychosocial Issues in Cancer Care | NCT00364078 | Lung Cancer Gastrointestina... | 21 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | ||
| Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R | NCT02045368 | Breast Cancer Brain Cancer Gastrointestina... Genitourinary C... Gynecologic Can... Head and Neck C... Melanoma Thoracic Cancer... | IGF-Methotrexat... | 18 Years - | IGF Oncology, LLC | |
| Electronic Patient Reported Outcomes in Patients With Gastrointestinal Cancers | NCT05359042 | Gastrointestina... Gastrointestina... | Electronic Pati... Health Related ... | 18 Years - | University of California, San Francisco | |
| Electronic Patient Reported Outcomes in Patients With Gastrointestinal Cancers | NCT05359042 | Gastrointestina... Gastrointestina... | Electronic Pati... Health Related ... | 18 Years - | University of California, San Francisco | |
| Vitamin D for Chemoprevention | NCT00585637 | Gastrointestina... Prostate Cancer Hypertension | Vitamin D Placebo | 30 Years - 80 Years | Dana-Farber Cancer Institute | |
| Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy | NCT00849979 | Gastrointestina... | Questionnaire Interview | 18 Years - | M.D. Anderson Cancer Center | |
| Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy | NCT03407040 | Gastrointestina... Breast Cancer Pancreatic Canc... Melanoma Lung Cancer | 15 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study | NCT02013089 | Gastrointestina... | Erlotinib or Ge... Everolimus Imatinib Sorafenib or Su... Vandetanib | 18 Years - 70 Years | Sun Yat-sen University | |
| Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy | NCT03407040 | Gastrointestina... Breast Cancer Pancreatic Canc... Melanoma Lung Cancer | 15 Years - | National Institutes of Health Clinical Center (CC) | ||
| Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models | NCT06002425 | Gastrointestina... | Clinician-Direc... ChatGPT-Assiste... | 18 Years - | Chinese Academy of Sciences | |
| A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer | NCT03929666 | HER2-expressing... | ZW25 (Zanidatam... Capecitabine Cisplatin Fluorouracil Leucovorin Oxaliplatin Bevacizumab Gemcitabine | 18 Years - | Jazz Pharmaceuticals | |
| Vitamin D for Chemoprevention | NCT00585637 | Gastrointestina... Prostate Cancer Hypertension | Vitamin D Placebo | 30 Years - 80 Years | Dana-Farber Cancer Institute | |
| Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy | NCT03407040 | Gastrointestina... Breast Cancer Pancreatic Canc... Melanoma Lung Cancer | 15 Years - | National Institutes of Health Clinical Center (CC) | ||
| Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R | NCT02045368 | Breast Cancer Brain Cancer Gastrointestina... Genitourinary C... Gynecologic Can... Head and Neck C... Melanoma Thoracic Cancer... | IGF-Methotrexat... | 18 Years - | IGF Oncology, LLC | |
| A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study | NCT02013089 | Gastrointestina... | Erlotinib or Ge... Everolimus Imatinib Sorafenib or Su... Vandetanib | 18 Years - 70 Years | Sun Yat-sen University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
